Triple-Pill Strategy Slashes Recurrent Stroke Risk by 39% in Groundbreaking TRIDENT Trial
April 23, 2026 In a major leap forward for stroke recovery and long-term prevention, a global clinical trial has found that a single "polypill"...
FDA Expands Breakthrough Type 1 Diabetes Therapy to Children as Young as 1
April 23, 2026 In a landmark decision for pediatric endocrinology, the U.S. Food and Drug Administration (FDA) has expanded the approval of Tzield...
Beyond the Neuron: Calcium ‘Morse Code’ in Brain Immune Cells Identified as Driver of Anxiety
SALT LAKE CITY — For decades, the quest to understand anxiety and obsessive-compulsive behaviors has focused almost exclusively on neurons—the...
Transparency Row: CDC Blocks Publication of Study Showing COVID-19 Vaccines Halved Hospitalization Risk
ATLANTA — A burgeoning controversy over scientific transparency is unfolding at the highest levels of federal health leadership. According to...
FDA Rejection of Replimune Cancer Therapy Sparks Political and Regulatory Debate: Secretary Kennedy Responds
April 23, 2026 In a high-stakes Senate hearing this week, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. addressed the...
